TY  - BOOK
AU  - Abramowitz, Steven D
TI  - Hemodialysis Vascular Access: Rising Costs as a Surrogate Marker for Patency and Function of Arteriovenous Fistulas
SN  - 0890-5096
PY  - 2017///
KW  - *Arteriovenous Shunt, Surgical/ec [Economics]
KW  - *Hospital Costs
KW  - *Kidney Failure, Chronic/ec [Economics]
KW  - *Kidney Failure, Chronic/th [Therapy]
KW  - *Renal Dialysis/ec [Economics]
KW  - *Vascular Patency
KW  - Aged
KW  - Arteriovenous Shunt, Surgical/ae [Adverse Effects]
KW  - Cost Control
KW  - Cost-Benefit Analysis
KW  - Female
KW  - Graft Occlusion, Vascular/ec [Economics]
KW  - Graft Occlusion, Vascular/et [Etiology]
KW  - Graft Occlusion, Vascular/th [Therapy]
KW  - Humans
KW  - Kidney Failure, Chronic/di [Diagnosis]
KW  - Male
KW  - Middle Aged
KW  - New York City
KW  - Registries
KW  - Retreatment/ec [Economics]
KW  - Retrospective Studies
KW  - Time Factors
KW  - Treatment Outcome
KW  - MedStar Washington Hospital Center
KW  - Surgery/Vascular Surgery
KW  - Journal Article
N1  - Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007
N2  - BACKGROUND: Establishment and maintenance of vascular access for hemodialysis is life-sustaining for patients needing renal-replacement therapy. Arteriovenous fistulas (AVFs) are the preferred type of access, but the costs associated with creation and maintenance are poorly characterized, especially with respect to patient characteristics; CONCLUSIONS: Hemodialysis access maintenance contributes significantly to the healthcare burden of renal disease. Our data suggest that particular patient characteristics factor into patency and costs. Short-term mounting costs associated with AVF maintenance may portend poor long-term patency. Rising healthcare costs cannot be easily controlled without understanding the clinical factors driving them; Copyright © 2016 Elsevier Inc. All rights reserved; METHODS: A prospectively maintained registry has been established at The Mount Sinai Hospital for patients undergoing access procedures since 2007. We studied 163 patients undergoing successfully placed and cannulated AVFs as their first permanent ipsilateral access and for whom 3-year follow-up was available, including 18 patients with failed contralateral AVFs. Records were analyzed for institutional inpatient and outpatient procedures related to access maturation, imaging, catheter-related procedures, and revisions. We determined hospital costs for 3 AVF locations, assessing the contribution of various factors to variation in costs and patency; RESULTS: The median first-year cost of patent AVFs was
UR  - https://dx.doi.org/10.1016/j.avsg.2016.08.003
ER  -